The importance of dosing intravenous calcitriol in dialysis patients with severe hyperparathyroidism
- 1 November 1995
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 26 (5) , 845-851
- https://doi.org/10.1016/0272-6386(95)90454-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Regulation of calcitriol receptor and its mRNA in normal and renal failure ratsKidney International, 1994
- Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidismKidney International, 1993
- Methods of controlling hyperphosphatemia in patients with chronic renal failureCurrent Opinion in Nephrology and Hypertension, 1993
- Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patientsKidney International, 1992
- Regulation of parathyroid hormone synthesis in chronic renal failure in ratsKidney International, 1991
- The Treatment of Uraemic Hyperphosphataemia with Calcium Acetate and Calcium Carbonate: A Comparative StudyNephrology Dialysis Transplantation, 1991
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- Reduced Binding of [3H]l,25-Dihydroxyvitamin D3in the Parathyroid Glands of Patients with Renal FailureNew England Journal of Medicine, 1987
- Homologous up-regulation of the 1,25 (OH)2 vitamin D3 receptor in ratsBiochemical and Biophysical Research Communications, 1986
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984